AssetMark Inc
EXAS

AssetMark Inc’s Exact Sciences EXAS Stock Holding History

AssetMark Inc’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,676
Closed -$170K – 3487
2025
Q4 		$170K Sell
1,676
-1,912
-53% -$154K ﹤0.01% 1337
2025
Q3 		$196K Buy
3,588
+242
+7% +$12.1K ﹤0.01% 1269
2025
Q2 		$178K Buy
3,346
+852
+34% +$43.3K ﹤0.01% 1249
2025
Q1 		$108K Sell
2,494
-320
-11% -$16.2K ﹤0.01% 1262
2024
Q4 		$158K Sell
2,814
-96
-3% -$5.97K ﹤0.01% 1153
2024
Q3 		$198K Sell
2,910
-262
-8% -$14.8K ﹤0.01% 1016
2024
Q2 		$134K Buy
3,172
+650
+26% +$35.8K ﹤0.01% 1063
2024
Q1 		$174K Sell
2,522
-513
-17% -$32.5K ﹤0.01% 962
2023
Q4 		$225K Buy
3,035
+851
+39% +$55.8K ﹤0.01% 903
2023
Q3 		$149K Buy
2,184
+335
+18% +$28.4K ﹤0.01% 924
2023
Q2 		$174K Buy
1,849
+994
+116% +$77.5K ﹤0.01% 865
2023
Q1 		$58K Buy
855
+236
+38% +$15.2K ﹤0.01% 997
2022
Q4 		$30.6K Buy
+619
New +$25.3K ﹤0.01% 1137
2022
Q2 		– Sell
-41
Closed -$3K – 1530
2022
Q1 		$3K Buy
41
+21
+105% +$1.53K ﹤0.01% 1355
2021
Q4 		$2K Buy
+20
New +$1.76K ﹤0.01% 1363

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

AssetMark Inc's EXAS Position: Q1 2026 in Review

AssetMark Inc sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,676 shares — an estimated $170K sold.

AssetMark Inc first reported a position in EXAS in Q4 2021 and held it in 15 quarters. The position peaked at $225K in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • AssetMark Inc reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • AssetMark Inc sold 1,676 Exact Sciences shares in Q1 2026, an estimated $170K.
  • AssetMark Inc first reported a position in Exact Sciences in Q4 2021 and held it in 15 quarters.
  • AssetMark Inc's Exact Sciences position peaked at $225K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.